Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in CALGB 50401 (Alliance)
      QxMD      Google Scholar   
Citation:
Lancet Haematol vol 7 (6) e490-e497
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-internal-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
Yes
Biospecimen:
No
SDC:
Yes
Book Volume:
9
Parents:
2706  
Children:
None
Program:
CCP
Primary Committee:
Health Outcomes
Sec. Committees:
Lymphoma    
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA189823, U10CA180790, UG1CA233339, P50 CA97274-14  
Corr. Author:
 
Authors:
                           
Networks:
LAPS-MN026, LAPS-MO011, LAPS-OH007, NY018   
Study
Alliance-A151617
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-50401
Phases:
N/A, 2
Keywords: